Getting to Precision Psychopharmacology in Child Psychiatry: The Value of Adverse Treatment Effects

Ginger E. Nicol; Iliyan Ivanov

doi:10.1089/cap.2021.29196.gni

Getting to Precision Psychopharmacology in Child Psychiatry: The Value of Adverse Treatment Effects

Ginger E. Nicol
, Iliyan Ivanov

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	Journal of Child and Adolescent Psychopharmacology
Volume	31
Issue number	1
DOIs	https://doi.org/10.1089/cap.2021.29196.gni
State	Published - Feb 1 2021

Access to Document

10.1089/cap.2021.29196.gni

Cite this

@article{ff22c852beec484082eef6a5ee7f8326,

title = "Getting to Precision Psychopharmacology in Child Psychiatry: The Value of Adverse Treatment Effects",

author = "Nicol, \{Ginger E.\} and Iliyan Ivanov",

note = "Funding Information: G.E.N. reports grant support from the US National Institute of Mental Health, the Barnes Jewish Hospital Foundation, the Center for Diabetes Translational Research, and the McDonnell Center for Systems Neuroscience at Washington University, and has consulted for Alkermes and Sunovion. I.I. reports research support from the National Institute on Drug Abuse, the Stanley foundation, the Addiction Institute at Mount Sinai and honoraria for participation as a member of the data monitoring board at Lundbeck.",

year = "2021",

month = feb,

day = "1",

doi = "10.1089/cap.2021.29196.gni",

language = "English",

volume = "31",

pages = "1--3",

journal = "Journal of Child and Adolescent Psychopharmacology",

issn = "1044-5463",

number = "1",

}

TY - JOUR

T1 - Getting to Precision Psychopharmacology in Child Psychiatry

T2 - The Value of Adverse Treatment Effects

AU - Nicol, Ginger E.

AU - Ivanov, Iliyan

N1 - Funding Information: G.E.N. reports grant support from the US National Institute of Mental Health, the Barnes Jewish Hospital Foundation, the Center for Diabetes Translational Research, and the McDonnell Center for Systems Neuroscience at Washington University, and has consulted for Alkermes and Sunovion. I.I. reports research support from the National Institute on Drug Abuse, the Stanley foundation, the Addiction Institute at Mount Sinai and honoraria for participation as a member of the data monitoring board at Lundbeck.

PY - 2021/2/1

Y1 - 2021/2/1

UR - https://www.scopus.com/pages/publications/85100943424

U2 - 10.1089/cap.2021.29196.gni

DO - 10.1089/cap.2021.29196.gni

M3 - Editorial

C2 - 33595415

AN - SCOPUS:85100943424

SN - 1044-5463

VL - 31

SP - 1

EP - 3

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

IS - 1

ER -

Getting to Precision Psychopharmacology in Child Psychiatry: The Value of Adverse Treatment Effects

Access to Document

Other files and links

Cite this